Predictive factors of pathological vascular invasion in hepatocellular carcinoma within 3cm and three nodules without radiological vascular invasion.

Abstract

The aim of this study was to determine the predictive factors of pathological vascular invasion as contra-indicators for ablation therapy in patients with hepatocellular carcinoma (HCC) within 3cm and three nodules without radiological vascular invasion. Two hundred and seventeen patients with HCC within 3cm and three nodules without radiological vascular invasion who underwent hepatic resection were retrospectively investigated. Pathological vascular invasion was positive in 46 patients, consisting of 38 portal vein invasions, three hepatic vein invasions, two hepatic artery invasions, one hepatic duct invasion and two with portal and hepatic vein invasions. In univariate analysis, patients with α-fetoprotein (AFP) of more than 100ng/mL had higher rates of pathological vascular invasion than those without. In addition, patients with protein induced by vitamin K absence (PIVKA-II) of more than 100mAU/mL had higher rates of pathological vascular invasion than those without. Multivariate analysis revealed that AFP of more than 100ng/mL and PIVKA-II of more than 100mAU/mL were independent predictive factors for pathological vascular invasion. As these patients were treated with hepatic resection, cumulative 5-year recurrence-free and overall survivals were not significantly different between the pathological vascular invasion negative and positive cases. AFP of more than 100ng/mL and PIVKA-II of more than 100mAU/mL can predict pathological vascular invasion in patients with HCC within 3cm and three nodules without radiological vascular invasion. In treating such cases, hepatic resection rather than local ablation therapy is recommended.